These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 25710756

  • 21. Effect of Firocoxib and Flunixin Meglumine on Large Colon Mural Thickness of Healthy Horses.
    Bishop RC, Wilkins PA, Kemper AM, Stewart RM, McCoy AM.
    J Equine Vet Sci; 2023 Jul; 126():104562. PubMed ID: 37172749
    [Abstract] [Full Text] [Related]

  • 22. In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia.
    McCann ME, Rickes EL, Hora DF, Cunningham PK, Zhang D, Brideau C, Black WC, Hickey GJ.
    Am J Vet Res; 2005 Jul; 66(7):1278-84. PubMed ID: 16111170
    [Abstract] [Full Text] [Related]

  • 23. Pharmacokinetics and pharmacodynamics of three formulations of firocoxib in healthy horses.
    Holland B, Fogle C, Blikslager AT, Curling A, Barlow BM, Schirmer J, Davis JL.
    J Vet Pharmacol Ther; 2015 Jun; 38(3):249-56. PubMed ID: 25378135
    [Abstract] [Full Text] [Related]

  • 24. Effect of selective versus nonselective cyclooxygenase inhibitors on gastric ulceration scores and intestinal inflammation in horses.
    Richardson LM, Whitfield-Cargile CM, Cohen ND, Chamoun-Emanuelli AM, Dockery HJ.
    Vet Surg; 2018 Aug; 47(6):784-791. PubMed ID: 30094858
    [Abstract] [Full Text] [Related]

  • 25. Pharmacokinetics of transdermal flunixin meglumine and effects on biomarkers of inflammation in horses.
    Knych HK, Arthur RM, Gretler SR, McKemie DS, Goldin S, Kass PH.
    J Vet Pharmacol Ther; 2021 Sep; 44(5):745-753. PubMed ID: 34173263
    [Abstract] [Full Text] [Related]

  • 26. Effect of firocoxib on cyclooxygenase 2, microsomal prostaglandin E2 synthase 1, and cytosolic phospholipase A2 gene expression in equine mononuclear cells.
    Barton MH, Darden JE, Clifton S, Vandenplas M.
    Am J Vet Res; 2015 Dec; 76(12):1051-7. PubMed ID: 26618729
    [Abstract] [Full Text] [Related]

  • 27. Effect of flunixin meglumine on selected physiologic and performance parameters of athletically conditioned thoroughbred horses subjected to an incremental exercise stress test.
    Colahan PT, Bailey JE, Chou CC, Johnson M, Rice BL, Jones GL, Cheeks JP.
    Vet Ther; 2002 Dec; 3(1):37-48. PubMed ID: 12050827
    [Abstract] [Full Text] [Related]

  • 28. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses.
    Semrad SD, Hardee GE, Hardee MM, Moore JN.
    Am J Vet Res; 1985 Dec; 46(12):2474-9. PubMed ID: 4083579
    [Abstract] [Full Text] [Related]

  • 29. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.
    Cheng Z, Nolan AM, McKellar QA.
    Inflammation; 1998 Aug; 22(4):353-66. PubMed ID: 9675607
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of flunixin meglumine in donkeys, mules, and horses.
    Coakley M, Peck KE, Taylor TS, Matthews NS, Mealey KL.
    Am J Vet Res; 1999 Nov; 60(11):1441-4. PubMed ID: 10566824
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro effects of reactive oxygen metabolites, with and without flunixin meglumine, on equine colonic mucosa.
    Inoue OJ, Freeman DE, Wallig MA, Clarkson RB.
    Am J Vet Res; 2007 Mar; 68(3):305-12. PubMed ID: 17331021
    [Abstract] [Full Text] [Related]

  • 34. Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome.
    Erkert RS, MacAllister CG, Payton ME, Clarke CR.
    Am J Vet Res; 2005 Feb; 66(2):284-8. PubMed ID: 15757129
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics of and serum thromboxane suppression by flunixin meglumine in healthy foals during the first month of life.
    Semrad SD, Sams RA, Ashcraft SM.
    Am J Vet Res; 1993 Dec; 54(12):2083-7. PubMed ID: 8116942
    [Abstract] [Full Text] [Related]

  • 37. Pharmacokinetics and anti-inflammatory effects of flunixin meglumine as a sole agent and in combination with phenylbutazone in exercised Thoroughbred horses.
    Knych HK, Arthur RM, McKemie DS, Baden RW, Seminoff K, Kass PH.
    Equine Vet J; 2021 Jan; 53(1):102-116. PubMed ID: 32145701
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effects of flunixin meglumine on postponement of ovulation in mares.
    Donnelly CG, Sones JL, Dockweiler JC, Norberg LA, Norberg LE, Cheong SH, Gilbert RO.
    Am J Vet Res; 2019 Mar; 80(3):306-310. PubMed ID: 30801209
    [Abstract] [Full Text] [Related]

  • 40. Thromboxane, prostaglandin I2 (epoprostenol), and the hemodynamic changes in equine endotoxin shock.
    Bottoms GD, Templeton CB, Fessler JF, Johnson MA, Roesel OF, Ewert KM, Adams SB.
    Am J Vet Res; 1982 Jun; 43(6):999-1002. PubMed ID: 7049018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.